Clinical Trials Browser

Phase 3 × INDUSTRY × HBM9161 × Clear all

NCT05039190 2023-03-08

MG

Phase 3 Completed

Myasthenia Gravis

NCT05332210 2023-03-08

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

Phase 3 Unknown

Myasthenia Gravis